Gene · 54880
Papers3,332
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,332
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development and validation of a novel prognosis prediction model for patients with myelodysplastic syndrome. | Front Oncol | 2022 | 36313674 | PubTator, text mining | PubMed |
| Increased prevalence of clonal hematopoiesis of indeterminate potential in hospitalized patients with COVID-19. | Front Immunol | 2022 | 36311800 | PubTator, text mining | PubMed |
| Different Gene Sets Are Associated With Azacitidine Response In Vitro Versus in Myelodysplastic Syndrome Patients. | Hemasphere | 2022 | 36310757 | PubTator, text mining | PubMed |
| High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study. | Blood Cancer J | 2022 | 36307399 | PubTator, text mining | PubMed |
| Comprehensive molecular characterization of a rare case of Philadelphia chromosome-positive acute myeloid leukemia. | Cold Spring Harb Mol Case Stud | 2022 | 36307214 | PubTator, text mining | PubMed |
| Discovery and functional characterization of the oncogenicity and targetability of a novel NOTCH1-ROS1 gene fusion in pediatric angiosarcoma. | Cold Spring Harb Mol Case Stud | 2022 | 36307212 | PubTator, text mining | PubMed |
| Primary intraosseous solitary fibrous tumor: an extremely rare case report and brief review of the literature. | Pathologica | 2022 | 36305024 | PubTator, text mining | PubMed |
| A growth-based platform for detecting domain-peptide interactions in the cytoplasm of mammalian cells. | Sci Rep | 2022 | 36302843 | PubTator, text mining | PubMed |
| Influence of Host Sialic Acid Receptors Structure on the Host Specificity of Influenza Viruses. | Viruses | 2022 | 36298694 | PubTator, text mining | PubMed |
| Novel Candidate Genes for Non-Syndromic Tooth Agenesis Identified Using Targeted Next-Generation Sequencing. | J Clin Med | 2022 | 36294409 | PubTator, text mining | PubMed |
| Rationale for Combining the BCL2 Inhibitor Venetoclax with the PI3K Inhibitor Bimiralisib in the Treatment of IDH2- and FLT3-Mutated Acute Myeloid Leukemia. | Int J Mol Sci | 2022 | 36293442 | PubTator, text mining | PubMed |
| Identification of Two Novel EPOR Gene Variants in Primary Familial Polycythemia: Case Report and Literature Review. | Genes (Basel) | 2022 | 36292571 | PubTator, text mining | PubMed |
| Clinical Practice of Targeted Capture Sequencing to Identify Actionable Alterations in Cholangiocarcinoma. | Cancers (Basel) | 2022 | 36291846 | PubTator, text mining | PubMed |
| Genetics Abnormalities with Clinical Impact in Primary Cutaneous Lymphomas. | Cancers (Basel) | 2022 | 36291756 | PubTator, text mining | PubMed |
| Mutational Landscape of Patients Referred for Elevated Hemoglobin Level. | Curr Oncol | 2022 | 36290845 | PubTator, text mining | PubMed |
| Epigenetic Features in Uterine Leiomyosarcoma and Endometrial Stromal Sarcomas: An Overview of the Literature. | Biomedicines | 2022 | 36289829 | PubTator, text mining | PubMed |
| BCOR variants are associated with X-linked recessive partial epilepsy. | Epilepsy Res | 2022 | 36279688 | PubTator, text mining | PubMed |
| Metanephric stromal tumor with BRAF V600E mutation in an adult patient: Case report and literature review. | Front Oncol | 2022 | 36276087 | PubTator, text mining | PubMed |
| SF3B1 mutations in AML are strongly associated with MECOM rearrangements and may be indicative of an MDS pre-phase. | Leukemia | 2022 | 36271152 | PubTator, text mining | PubMed |
| Pulmonary Epithelial-Myoepithelial Carcinoma. | J Oncol | 2022 | 36268279 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54880/papers?page=44